GH Research Plc (GHRS)
26.98
-0.96
(-3.44%)
USD |
NASDAQ |
Aug 31, 16:00
26.97
-0.01
(-0.04%)
After-Hours: 20:00
GH Research Cash from Operations (TTM) : -52.32M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -52.32M |
| March 31, 2026 | -47.01M |
| December 31, 2025 | -44.92M |
| September 30, 2025 | -42.18M |
| June 30, 2025 | -40.44M |
| March 31, 2025 | -40.66M |
| December 31, 2024 | -41.69M |
| September 30, 2024 | -39.91M |
| June 30, 2024 | -37.60M |
| March 31, 2024 | -35.87M |
| Date | Value |
|---|---|
| December 31, 2023 | -33.16M |
| September 30, 2023 | -32.63M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -19.69M |
| December 31, 2021 | -14.78M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Atai Beckley, Inc. | -128.93M |
| Avadel Pharmaceuticals Plc | 37.01M |
| Jazz Pharmaceuticals Plc | 1.661B |
| Eli Lilly & Co. | 28.08B |
| Perrigo Co. Plc | 196.10M |